Dysregulation of lncRNAs, including DSCAM-AS1, SNHG15, and HOXA1-AS, has been implicated in breast cancer development and progression, and is correlated with prognosis [15, 33, 34]. This evidence concerns the gene DSCAM and breast carcinoma.